Beskrovnaya Oxana has filed 37 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 2153 shares of Dyne Therapeutics, Inc. ($DYN) on March 11, 2025.
Activity breakdown: 0 open-market purchases and 26 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2025 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2153 | $11.38 | 195,840.0000 | 113,121,357 | 1.09% | 0.00% |
| March 5, 2025 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1094 | $11.83 | 197,993.0000 | 113,121,357 | 0.55% | 0.00% |
| Feb. 18, 2025 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2598 | $13.95 | 199,087.0000 | 0 | 1.29% | 0.00% |
| Dec. 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2334 | $28.12 | 201,685.0000 | 0 | 1.14% | 0.00% |
| Dec. 4, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | A | Common Stock | 39100 | $0.00 | 176,619.0000 | 0 | 28.43% | 0.00% |
| Dec. 4, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | A | Common Stock | 27400 | $0.00 | 204,019.0000 | 0 | 15.51% | 0.00% |
| Dec. 4, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | A | Stock option (right to buy) | 62400 | $0.00 | 62,400.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2856 | $28.20 | 137,519.0000 | 0 | 2.03% | 0.00% |
| Sept. 18, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2339 | $34.55 | 140,375.0000 | 0 | 1.64% | 0.00% |
| Sept. 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2161 | $31.89 | 142,714.0000 | 0 | 1.49% | 0.00% |
| Aug. 19, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2340 | $45.01 | 145,171.0000 | 0 | 1.59% | 0.00% |
| Aug. 19, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 296 | $46.00 | 144,875.0000 | 0 | 0.20% | 0.00% |
| June 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2136 | $31.34 | 147,511.0000 | 0 | 1.43% | 0.00% |
| May 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | M | Common Stock | 30426 | $1.03 | 180,073.0000 | 0 | 20.33% | 0.00% |
| May 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 17134 | $32.49 | 162,939.0000 | 0 | 9.52% | 0.00% |
| May 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 12147 | $33.51 | 150,792.0000 | 0 | 7.45% | 0.00% |
| May 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1145 | $34.08 | 149,647.0000 | 0 | 0.76% | 0.00% |
| May 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | M | Stock option (right to buy) | 30426 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2222 | $28.20 | 150,130.0000 | 0 | 1.46% | 0.00% |
| May 16, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 483 | $28.59 | 149,647.0000 | 0 | 0.32% | 0.00% |
| March 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2081 | $25.70 | 152,352.0000 | 0 | 1.35% | 0.00% |
| March 7, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2373 | $25.85 | 154,433.0000 | 0 | 1.51% | 0.00% |
| Jan. 3, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | M | Common Stock | 45326 | $1.03 | 221,911.0000 | 0 | 25.67% | 0.00% |
| Jan. 3, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 15382 | $18.34 | 206,529.0000 | 0 | 6.93% | 0.00% |
| Jan. 3, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 24583 | $19.05 | 181,946.0000 | 0 | 11.90% | 0.00% |
| Jan. 3, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 5361 | $20.50 | 176,585.0000 | 0 | 2.95% | 0.00% |
| Jan. 4, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | M | Common Stock | 22674 | $1.03 | 199,259.0000 | 0 | 12.84% | 0.00% |
| Jan. 4, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 42453 | $18.13 | 156,806.0000 | 0 | 21.31% | 0.00% |
| Jan. 3, 2024 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | M | Stock option (right to buy) | 45326 | $0.00 | 53,100.0000 | 0 | 46.05% | 0.00% |
| Jan. 4, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | M | Stock option (right to buy) | 22674 | $0.00 | 30,426.0000 | 0 | 42.70% | 0.00% |
| Dec. 11, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1467 | $10.72 | 176,585.0000 | 0 | 0.82% | 0.00% |
| Nov. 15, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | A | Common Stock | 93718 | $0.00 | 178,052.0000 | 0 | 111.13% | 0.00% |
| Nov. 15, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | A | Stock Option (right to buy) | 36495 | $0.00 | 36,495.0000 | 0 | 9999.99% | 0.00% |
| Sept. 18, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1436 | $9.41 | 84,334.0000 | 0 | 1.67% | 0.00% |
| Sept. 12, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1484 | $10.41 | 85,770.0000 | 0 | 1.70% | 0.00% |
| June 13, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1475 | $12.43 | 87,254.0000 | 0 | 1.66% | 0.00% |
| March 14, 2023 | Dyne Therapeutics, Inc. | $DYN | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1416 | $13.33 | 88,729.0000 | 0 | 1.57% | 0.00% |